Association between urinary free light chains and progression to end stage renal disease in chronic kidney disease
![Cureus | Myeloma Cast Nephropathy and COVID-19: A Case Report of Multiple Myeloma Presenting as Acute Kidney Injury in the Setting of COVID-19 Cureus | Myeloma Cast Nephropathy and COVID-19: A Case Report of Multiple Myeloma Presenting as Acute Kidney Injury in the Setting of COVID-19](https://assets.cureus.com/uploads/figure/file/201080/e7642b908cab11ebb6dc41be07f314aa-Image-15.png)
Cureus | Myeloma Cast Nephropathy and COVID-19: A Case Report of Multiple Myeloma Presenting as Acute Kidney Injury in the Setting of COVID-19
![Frontiers | Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency? | Immunology Frontiers | Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency? | Immunology](https://www.frontiersin.org/files/Articles/561146/fimmu-11-02004-HTML/image_m/fimmu-11-02004-g001.jpg)
Frontiers | Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency? | Immunology
![Kappa-Free Light Chains in CSF Predict Early Multiple Sclerosis Disease Activity | Neurology Neuroimmunology & Neuroinflammation Kappa-Free Light Chains in CSF Predict Early Multiple Sclerosis Disease Activity | Neurology Neuroimmunology & Neuroinflammation](https://nn.neurology.org/content/nnn/8/4/e1005/F2.large.jpg)
Kappa-Free Light Chains in CSF Predict Early Multiple Sclerosis Disease Activity | Neurology Neuroimmunology & Neuroinflammation
![Kappa and lambda immunohistochemistry and in situ hybridization in the evaluation of atypical cutaneous lymphoid infiltrates - Hristov - 2020 - Journal of Cutaneous Pathology - Wiley Online Library Kappa and lambda immunohistochemistry and in situ hybridization in the evaluation of atypical cutaneous lymphoid infiltrates - Hristov - 2020 - Journal of Cutaneous Pathology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/ec451350-c748-4112-a036-ef938dcc377c/cup13858-fig-0002-m.jpg)
Kappa and lambda immunohistochemistry and in situ hybridization in the evaluation of atypical cutaneous lymphoid infiltrates - Hristov - 2020 - Journal of Cutaneous Pathology - Wiley Online Library
![Prognostic value of kappa free light chains determination in first-ever multiple sclerosis relapse - Journal of Neuroimmunology Prognostic value of kappa free light chains determination in first-ever multiple sclerosis relapse - Journal of Neuroimmunology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/da9028c7-14a9-44c1-b4ad-50df2dad7d84/ga1_lrg.jpg)
Prognostic value of kappa free light chains determination in first-ever multiple sclerosis relapse - Journal of Neuroimmunology
![Kappa-Free Light Chains in CSF Predict Early Multiple Sclerosis Disease Activity | Neurology Neuroimmunology & Neuroinflammation Kappa-Free Light Chains in CSF Predict Early Multiple Sclerosis Disease Activity | Neurology Neuroimmunology & Neuroinflammation](https://nn.neurology.org/sites/default/files/highwire/nnn/8/4.cover-source.jpg)
Kappa-Free Light Chains in CSF Predict Early Multiple Sclerosis Disease Activity | Neurology Neuroimmunology & Neuroinflammation
![Clinical recommendations for the measurement of serum free light chains and the emerging role of heavy/light chain pair analysis in the management of monoclonal gammopathies: When and how to use it? Jiménez Clinical recommendations for the measurement of serum free light chains and the emerging role of heavy/light chain pair analysis in the management of monoclonal gammopathies: When and how to use it? Jiménez](https://www.jahjournal.org/articles/2015/6/2/images/JApplHematol_2015_6_2_43_160196_u5.jpg)
Clinical recommendations for the measurement of serum free light chains and the emerging role of heavy/light chain pair analysis in the management of monoclonal gammopathies: When and how to use it? Jiménez
![Frontiers | CSF Free Light Chains as a Marker of Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large Cohort | Immunology Frontiers | CSF Free Light Chains as a Marker of Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large Cohort | Immunology](https://www.frontiersin.org/files/MyHome%20Article%20Library/437789/437789_Thumb_400.jpg)
Frontiers | CSF Free Light Chains as a Marker of Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large Cohort | Immunology
![PTOV1 promotes cisplatin-induced chemotherapy resistance by activating the nuclear factor kappa B pathway in ovarian cancer: Molecular Therapy - Oncolytics PTOV1 promotes cisplatin-induced chemotherapy resistance by activating the nuclear factor kappa B pathway in ovarian cancer: Molecular Therapy - Oncolytics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/0a7d4171-24ae-434f-bbc8-632bb35523f5/fx1_lrg.jpg)
PTOV1 promotes cisplatin-induced chemotherapy resistance by activating the nuclear factor kappa B pathway in ovarian cancer: Molecular Therapy - Oncolytics
![Serum immunoglobulin free light chains and their association with clinical phenotypes, serology and activity in patients with IgG4-related disease | Scientific Reports Serum immunoglobulin free light chains and their association with clinical phenotypes, serology and activity in patients with IgG4-related disease | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-021-81321-5/MediaObjects/41598_2021_81321_Fig5_HTML.png)
Serum immunoglobulin free light chains and their association with clinical phenotypes, serology and activity in patients with IgG4-related disease | Scientific Reports
![Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties | PNAS Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties | PNAS](https://www.pnas.org/content/pnas/117/1/292/F3.large.jpg)